{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T21:34:47Z","timestamp":1788298487763,"version":"build-2803163510"},"reference-count":39,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jvir.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Vascular and Interventional Radiology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jvir.2025.08.037","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T16:30:12Z","timestamp":1763742612000},"page":"1831-1838","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Nanoparticles as Multifunctional Drug-Delivery Systems: A Comprehensive Review and Integration into Interventional Oncology"],"prefix":"10.1016","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5957-3389","authenticated-orcid":false,"given":"Kentaro","family":"Yamada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3040-0625","authenticated-orcid":false,"given":"Takeshi","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3127-7147","authenticated-orcid":false,"given":"Khashayar","family":"Farsad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvir.2025.08.037_bib1","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.3390\/ph17081057","article-title":"Hypoxia as a target for combination with transarterial chemoembolization in hepatocellular carcinoma","volume":"17","author":"Wang","year":"2024","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.jvir.2025.08.037_bib2","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/hep.28453","article-title":"Lipiodol transarterial chemoembolization for hepatocellular carcinoma: a systematic review of efficacy and safety data","volume":"64","author":"Lencioni","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jvir.2025.08.037_bib3","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.3390\/nano13212887","article-title":"Application of nanoparticles in cancer treatment: a concise review","volume":"13","author":"Sell","year":"2023","journal-title":"Nanomaterials (Basel)"},{"key":"10.1016\/j.jvir.2025.08.037_bib4","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s10238-023-01262-3","article-title":"Recent nanotheranostic approaches in cancer research","volume":"24","author":"Gupta","year":"2024","journal-title":"Clin Exp Med"},{"key":"10.1016\/j.jvir.2025.08.037_bib5","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s11671-021-03628-6","article-title":"Nanoparticles for cancer therapy: current progress and challenges","volume":"16","author":"Gavas","year":"2021","journal-title":"Nanoscale Res Lett"},{"key":"10.1016\/j.jvir.2025.08.037_bib6","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","article-title":"Lipid nanoparticles for mRNA delivery","volume":"6","author":"Hou","year":"2021","journal-title":"Nat Rev Mater"},{"key":"10.1016\/j.jvir.2025.08.037_bib7","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jconrel.2012.03.020","article-title":"Doxil\u00ae--the first FDA-approved nano-drug: lessons learned","volume":"160","author":"Barenholz","year":"2012","journal-title":"J Control Release"},{"key":"10.1016\/j.jvir.2025.08.037_bib8","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.tibtech.2014.06.010","article-title":"Mechanisms of cooperation in cancer nanomedicine: towards systems nanotechnology","volume":"32","author":"Hauert","year":"2014","journal-title":"Trends Biotechnol"},{"key":"10.1016\/j.jvir.2025.08.037_bib9","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/s41419-017-0061-0","article-title":"Defining the role of the tumor vasculature in antitumor immunity and immunotherapy","volume":"9","author":"Schaaf","year":"2018","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.jvir.2025.08.037_bib10","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/s41563-019-0566-2","article-title":"The entry of nanoparticles into solid tumours","volume":"19","author":"Sindhwani","year":"2020","journal-title":"Nat Mater"},{"key":"10.1016\/j.jvir.2025.08.037_bib11","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1038\/s41563-023-01630-0","article-title":"The exit of nanoparticles from solid tumours","volume":"22","author":"Nguyen","year":"2023","journal-title":"Nat Mater"},{"key":"10.1016\/j.jvir.2025.08.037_bib12","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.addr.2010.04.009","article-title":"The EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect","volume":"63","author":"Fang","year":"2011","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.jvir.2025.08.037_bib13","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202500521","article-title":"Blood-brain barrier-penetrating nanocarriers enable microglial-specific drug delivery in hypothalamic neuroinflammation","volume":"14","author":"Goo","year":"2025","journal-title":"Adv Healthc Mater"},{"key":"10.1016\/j.jvir.2025.08.037_bib14","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1016\/S0959-8049(01)00171-X","article-title":"Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation","volume":"37","author":"Gelderblom","year":"2001","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jvir.2025.08.037_bib15","doi-asserted-by":"crossref","first-page":"7794","DOI":"10.1200\/JCO.2005.04.937","article-title":"Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer","volume":"23","author":"Gradishar","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jvir.2025.08.037_bib16","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.21037\/atm-21-1948","article-title":"A narrative review of tumor heterogeneity and challenges to tumor drug therapy","volume":"9","author":"Zhu","year":"2021","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.jvir.2025.08.037_bib17","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1073\/pnas.1018382108","article-title":"Multistage nanoparticle delivery system for deep penetration into tumor tissue","volume":"108","author":"Wong","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jvir.2025.08.037_bib18","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1080\/10717544.2017.1388451","article-title":"Cleavable PEGylation: a strategy for overcoming the \"PEG dilemma\" in efficient drug delivery","volume":"24","author":"Fang","year":"2017","journal-title":"Drug Deliv"},{"key":"10.1016\/j.jvir.2025.08.037_bib19","doi-asserted-by":"crossref","first-page":"4313","DOI":"10.1039\/D5TB00026B","article-title":"Sequential drug release nanocomposites for synergistic therapy in disease treatment","volume":"13","author":"Luo","year":"2025","journal-title":"J Mater Chem B"},{"key":"10.1016\/j.jvir.2025.08.037_bib20","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1038\/s41467-022-31926-9","article-title":"Development of a nanoparticle-based immunotherapy targeting PD-L1 and PLK1 for lung cancer treatment","volume":"13","author":"Reda","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.jvir.2025.08.037_bib21","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/nrc.2016.108","article-title":"Cancer nanomedicine: progress, challenges and opportunities","volume":"17","author":"Shi","year":"2017","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jvir.2025.08.037_bib22","doi-asserted-by":"crossref","DOI":"10.1002\/wnan.1749","article-title":"Recent advances and applications of microspheres and nanoparticles in transarterial chemoembolization for hepatocellular carcinoma","volume":"14","author":"Jia","year":"2022","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"key":"10.1016\/j.jvir.2025.08.037_bib23","doi-asserted-by":"crossref","first-page":"7579","DOI":"10.1021\/acsami.1c19121","article-title":"Doxorubicin-loaded UiO-66\/Bi2S3 nanocomposite-enhanced synergistic transarterial chemoembolization and photothermal therapy against hepatocellular carcinoma","volume":"14","author":"Liu","year":"2022","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.jvir.2025.08.037_bib24","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s12951-023-01820-7","article-title":"Multifunctional nanoplatforms application in the transcatheter chemoembolization against hepatocellular carcinoma","volume":"21","author":"Yuan","year":"2023","journal-title":"J Nanobiotechnology"},{"key":"10.1016\/j.jvir.2025.08.037_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114505","article-title":"Image-guided intratumoral immunotherapy: developing a clinically practical technology","volume":"189","author":"Som","year":"2022","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.jvir.2025.08.037_bib26","doi-asserted-by":"crossref","first-page":"4223","DOI":"10.1038\/s41467-023-39938-9","article-title":"mRNA lipid nanoparticle-mediated pyroptosis sensitizes immunologically cold tumors to checkpoint immunotherapy","volume":"14","author":"Li","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.jvir.2025.08.037_bib27","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1038\/s43018-020-0095-6","article-title":"Multifunctional oncolytic nanoparticles deliver self-replicating IL-12 RNA to eliminate established tumors and prime systemic immunity","volume":"1","author":"Li","year":"2020","journal-title":"Nat Cancer"},{"key":"10.1016\/j.jvir.2025.08.037_bib28","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.nano.2017.10.013","article-title":"Biodegradable STING agonist nanoparticles for enhanced cancer immunotherapy","volume":"14","author":"Wilson","year":"2018","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jvir.2025.08.037_bib29","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1038\/s41467-023-37328-9","article-title":"STING agonist-loaded, CD47\/PD-L1-targeting nanoparticles potentiate antitumor immunity and radiotherapy for glioblastoma","volume":"14","author":"Zhang","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.jvir.2025.08.037_bib30","doi-asserted-by":"crossref","first-page":"4241","DOI":"10.2147\/IJN.S129748","article-title":"Stepwise pH-responsive nanoparticles for enhanced cellular uptake and on-demand intracellular release of doxorubicin","volume":"12","author":"Chen","year":"2017","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.jvir.2025.08.037_bib31","doi-asserted-by":"crossref","first-page":"4073","DOI":"10.2147\/IJN.S308057","article-title":"Intratumoral administration of Thermosensitive Hydrogel Co-Loaded with Norcantharidin Nanoparticles and Doxorubicin for the Treatment of Hepatocellular Carcinoma","volume":"16","author":"Gao","year":"2021","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.jvir.2025.08.037_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120848","article-title":"Recent advances in nanoparticles mediated photothermal therapy induced tumor regression","volume":"606","author":"Kumar","year":"2021","journal-title":"Int J Pharm"},{"key":"10.1016\/j.jvir.2025.08.037_bib33","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/s41420-024-02236-4","article-title":"Advances in smart nanotechnology-supported photodynamic therapy for cancer","volume":"10","author":"Li","year":"2024","journal-title":"Cell Death Discov"},{"key":"10.1016\/j.jvir.2025.08.037_bib34","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202003214","article-title":"Recent advances in nanomaterial-assisted combinational sonodynamic cancer therapy","volume":"32","author":"Liang","year":"2020","journal-title":"Adv Mater"},{"key":"10.1016\/j.jvir.2025.08.037_bib35","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202414719","article-title":"Precision-engineered cobalt-doped iron oxide nanoparticles: from octahedron seeds to cubical bipyramids for enhanced magnetic hyperthermia","author":"Singh","year":"2025","journal-title":"Adv Funct Mater"},{"key":"10.1016\/j.jvir.2025.08.037_bib36","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.1021\/acsami.4c16129","article-title":"Preclinical development of magnetic nanoparticles for hyperthermia treatment of pancreatic cancer","volume":"17","author":"Diaz-Riascos","year":"2025","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.jvir.2025.08.037_bib37","doi-asserted-by":"crossref","first-page":"S140","DOI":"10.1016\/j.jvir.2024.12.366","article-title":"Abstract No. 307 \u25aa FEATURED ABSTRACT Enhanced local drug accumulation via intra-arterial administration of magnetic nanoparticles and hyperthermia induced antitumor effects in a rat pancreatic cancer model","volume":"36","author":"Yamada","year":"2025","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.jvir.2025.08.037_bib38","doi-asserted-by":"crossref","DOI":"10.1002\/smsc.202570013","article-title":"Therapeutic glypican-3 CRISPR genome-editing using ultralarge porous silica nano-depot for the treatment of hepatocellular carcinoma","volume":"5","author":"Lee","year":"2025","journal-title":"Small Sci"},{"key":"10.1016\/j.jvir.2025.08.037_bib39","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1056\/NEJMoa2107454","article-title":"CRISPR-Cas9 in vivo gene editing for transthyretin amyloidosis","volume":"385","author":"Gillmore","year":"2021","journal-title":"N Engl J Med"}],"container-title":["Journal of Vascular and Interventional Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1051044325005780?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1051044325005780?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T23:24:03Z","timestamp":1763767443000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1051044325005780"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":39,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S1051044325005780"],"URL":"https:\/\/doi.org\/10.1016\/j.jvir.2025.08.037","relation":{},"ISSN":["1051-0443"],"issn-type":[{"value":"1051-0443","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nanoparticles as Multifunctional Drug-Delivery Systems: A Comprehensive Review and Integration into Interventional Oncology","name":"articletitle","label":"Article Title"},{"value":"Journal of Vascular and Interventional Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvir.2025.08.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 SIR, 2025","name":"copyright","label":"Copyright"}]}}